# Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin

> **NCT02029014** · PHASE3 · UNKNOWN · sponsor: **Lifetech Scientific (Shenzhen) Co., Ltd.** · enrollment: 154 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** LAA closure system

## Key facts

- **NCT ID:** NCT02029014
- **Lead sponsor:** Lifetech Scientific (Shenzhen) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2016-03
- **Final completion:** 2016-07
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2014-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02029014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02029014, "Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin". Retrieved via AI Analytics 2026-06-19 from https://api.ai-analytics.org/clinical/NCT02029014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*